Lebers hereditary optic neuropathy
Overview of Leber's Hereditary Optic Neuropathy (LHON)
LHON is a hereditary optic neuropathy characterized by vision loss.
Discovered by a German ophthalmologist in 1871; originally thought to be X-linked due to its male dominance.
In 1988, linked to mitochondrial DNA mutations by Douglas Wallace.
Specific mutations identified in 1992.
Symptoms and Onset
Main Symptom: Bilateral vision loss, which is progressive (gets worse over time).
Usually presents suddenly between ages 20-30, worsening over 6 months to a year, eventually plateauing.
Central scotoma: a dark spot in central vision that enlarges over time.
Asynchronous vision loss: often starts in one eye before the other.
Associated conditions:
Death of retinal ganglion cells (RGCs).
Optic neuropathy (issues with the optic nerve).
Retinal nerve fiber and optic disc edema.
Blood vessel tortuosity (curled blood vessels).
Specific Conditions Related to LHON
Leber's Plus: A variant where visual symptoms are accompanied by neurological issues like dystonia and ataxia.
Common Genetic Mutations Associated with LHON
Three common mutations linked with LHON affecting complex I of the mitochondrial electron transport chain (ETC):
mtdn1 (3460): Guanine to adenine; least severe, minimal respiratory chain effect.
mtdn4 (11778): Guanine to adenine; lowest chance of visual improvement, associated with color blindness.
mtdn6 (14484): Cytosine mutation; highest chance of visual recovery, spontaneous recovery possible.
Mode of Inheritance
LHON is inherited via mitochondrial DNA (mtDNA), always maternal.
Homoplasmy vs. Heteroplasmy:
Homoplasmy: Same mutation in all mitochondria.
Heteroplasmy: A mixture of mutated and normal mtDNA in different mitochondria.
Mitochondrial Function
Mitochondrial DNA encodes proteins critical for ATP production via the ETC (electron transport chain).
Complex I initiates the process by oxidizing NADH to produce energy.
Dysfunction in ETC leads to the production of reactive oxygen species (ROS), which can damage tissues and cells, particularly RGCs.
Impact of LHON Mutations on ETC
Mutations disrupt complex I formation and function, leading to reduced ATP production and increased ROS.
This causes death of RGCs as they depend on ATP, resulting in vision loss due to impaired signal transmission to the brain.
Case Study: Hormone Replacement Therapy (2019)
Case of a 48-year-old woman with bilateral vision loss post hormone discontinuation, initially misdiagnosed with optic neuritis.
Treatment included Idebenone, Vitamin C, restarting hormonal birth control, and reducing alcohol intake.
Visual field examinations showed significant improvements over time, indicating Idebenone's effectiveness for vision recovery.
Factors Influencing Vision Loss in LHON
Estrogen Influence: Possible protective effects from estrogen, especially in postmenopausal women.
Alcohol Consumption: High alcohol intake linked to increased ROS, potentially exacerbating vision loss.
Higher rates of LHON observed in males; potential reasons:
Estrogen's protective mechanism.
Underdiagnosis in females due to misidentification with more common conditions like optic neuritis or multiple sclerosis.
The Role of Environmental Factors
Environmental ROS from lifestyle choices (e.g., alcohol and smoking) can contribute to vision loss in LHON.
Patients with lifestyle habits less likely to produce high ROS levels tend to have better outcomes.
Diagnosis Challenges
Misdiagnosis common due to symptom similarity with optic neuritis (painful condition), whereas LHON is painless.
Importance of differentiation based on symptom profiles and genetic testing.